Garadacimab (CSL312) is a first-in-class, fully human IgG4 monoclonal antibody targeting activated factor XII (FXIIa). Garadacimab has the potential for hereditary angioedema research.
Purity:
95.0%
CAS Number:
[2162134-62-3]
* VAT and and shipping costs not included. Errors and price changes excepted
